Compare WEYS & USBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WEYS | USBC |
|---|---|---|
| Founded | 1906 | N/A |
| Country | United States | |
| Employees | N/A | 6 |
| Industry | Apparel | |
| Sector | Consumer Staples | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 280.9M | 333.2M |
| IPO Year | N/A | N/A |
| Metric | WEYS | USBC |
|---|---|---|
| Price | $34.18 | $0.72 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 17.0K | N/A |
| Earning Date | 11-04-2025 | N/A |
| Dividend Yield | ★ 3.16% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.54 | N/A |
| Revenue | ★ $279,843,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $13.43 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $25.51 | N/A |
| 52 Week High | $38.24 | N/A |
| Indicator | WEYS | USBC |
|---|---|---|
| Relative Strength Index (RSI) | 56.89 | 41.51 |
| Support Level | $33.48 | $0.67 |
| Resistance Level | $34.44 | $0.91 |
| Average True Range (ATR) | 1.10 | 0.07 |
| MACD | 0.20 | -0.00 |
| Stochastic Oscillator | 69.18 | 17.61 |
Weyco Group Inc is a company, engaged in the manufacturing, designing, and distribution of footwear. The company designs and markets footwear for men, women, and children. It markets its apparel, accessories, and footwear under the brand names of Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. The company organizes its business into two segments; the North American wholesale operations and the North American retail operations. The majority of the company's revenue is generated from the wholesale segment under which its products are sold to footwear, department, and specialty stores, as well as e-commerce retailers. The company has operational footprints in the United States which generates key revenue, Canada, Asia, South Africa, and Australia.
USBC Inc is a non-invasive medical diagnostics. The group is focused on the development and commercialization of proprietary sensor technology utilizing radio and microwave dielectric spectroscopy. Its Sensor technology elicits a dielectric response that is different for every molecule. The group considers the business to currently have one operating segment: the development of its radio frequency spectroscopy technology, with a first focus on non-invasively ascertaining blood glucose levels.